Oa. Andreassen et al., Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice, EXP NEUROL, 168(2), 2001, pp. 419-424
The development of transgenic mouse models of amyotrophic lateral sclerosis
(ALS) allows the testing of neuroprotective agents. We evaluated the effec
ts of five agents in transgenic mice with the G93A Cu,Zn superoxide dismuta
se mutation. A novel inhibitor of poly(ADP-ribose) polymerase showed no eff
ects on survival. Desmethylselegiline and CGP3466 are agents that exert ant
iapoptotic effects in vitro by preventing nuclear translocation of glyceral
dehyde-3-phosphate dehydrogenase, They had no significant effects on surviv
al in the G93A mice. Trientine, a copper chelator, produced a modest signif
icant increase in survival, Similarly administration of lipoic acid in the
diet produced a significant improvement in survival. These results therefor
e provide evidence for potential therapeutic effects of copper chelators an
d lipoic acid in the treatment of ALS. (C) 2001 Academic Press.